US Patent Issued to AIM Targeted Therapies on Dec. 2 for "Hypertonic antimicrobial therapeutic compositions" (Florida Inventor)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,175, issued on Dec. 2, was assigned to AIM Targeted Therapies Inc. (Key Biscayne, Fla.).

"Hypertonic antimicrobial therapeutic compositions" was invented by Glenn Abrahmsohn (Key Biscayne, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Therapeutic compositions, primarily for topical application, and methods of making and using the composition. Pharmaceutical compositions formulated for specific forms of administration are also provided."

The patent was filed on June 27, 2024, under Application No. 18/757,012.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=...